edistride
astrazeneca ab - dapagliflozin propandiol monohidrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - lijekovi koji se koriste u dijabetesu - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. osim drugih lijekova za liječenje šećerne bolesti tipa 2 . for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 i 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.
dafiro
novartis europharm limited - amlodipin, валсартан - hipertenzija - sredstva koja djeluju na sustav renin-angiotenzina - liječenje esencijalne hipertenzije. dafiro indiciran kod pacijenata kod kojih je krvni pritisak nije dovoljno prati na amlodipin ili валсартан kao monoterapija.
jalra
novartis europharm limited - vildagliptin - dijabetes mellitus, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).
zomarist
novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - lijekovi koji se koriste u dijabetesu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.
revitacam
zoetis belgium sa - mcloksikam - oxicams - psi - olakšanje upala i bolova u akutni i kronični mišićno-koštanog sustava u pasa.
hyperil plus 20 mg/1 tableta+ 25 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - hidrohlorotiazid, lizinopril - tableta - 20 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 20 mg lizinoprila (u obliku lizinopril dihidrata) i 25 mg hidrohlorotiazida
spilak 25 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - спиронолактона - film tableta - 25 mg/1 tableta - 1 film tableta sadrži: 25 mg spironolaktona
spilak 50 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - спиронолактона - film tableta - 50 mg/1 tableta - 1 film tableta sadrži: 50 mg spirinolaktona
moxi 400 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - moksifloksacin - film tableta - 400 mg/1 tableta - 1 film tableta sadrži 400 mg moksifloksacina (u obliku moksifloksacinhidrohlorida)
moxi 400 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - moksifloksacin - film tableta - 400 mg/1 tableta - 1 film tableta sadrži 400 mg moksifloksacin (u obliku moksifloksacinhidrohlorida)